位置:首页 > 蛋白库 > RN146_AILME
RN146_AILME
ID   RN146_AILME             Reviewed;         359 AA.
AC   D2H0Y8;
DT   31-MAY-2011, integrated into UniProtKB/Swiss-Prot.
DT   09-FEB-2010, sequence version 1.
DT   03-AUG-2022, entry version 72.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF146;
DE            EC=2.3.2.27;
DE   AltName: Full=Iduna;
DE   AltName: Full=RING finger protein 146;
DE   AltName: Full=RING-type E3 ubiquitin transferase RNF146 {ECO:0000305};
GN   Name=RNF146; ORFNames=PANDA_003130;
OS   Ailuropoda melanoleuca (Giant panda).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Carnivora; Caniformia; Ursidae; Ailuropoda.
OX   NCBI_TaxID=9646;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=20010809; DOI=10.1038/nature08696;
RA   Li R., Fan W., Tian G., Zhu H., He L., Cai J., Huang Q., Cai Q., Li B.,
RA   Bai Y., Zhang Z., Zhang Y., Wang W., Li J., Wei F., Li H., Jian M., Li J.,
RA   Zhang Z., Nielsen R., Li D., Gu W., Yang Z., Xuan Z., Ryder O.A.,
RA   Leung F.C., Zhou Y., Cao J., Sun X., Fu Y., Fang X., Guo X., Wang B.,
RA   Hou R., Shen F., Mu B., Ni P., Lin R., Qian W., Wang G., Yu C., Nie W.,
RA   Wang J., Wu Z., Liang H., Min J., Wu Q., Cheng S., Ruan J., Wang M.,
RA   Shi Z., Wen M., Liu B., Ren X., Zheng H., Dong D., Cook K., Shan G.,
RA   Zhang H., Kosiol C., Xie X., Lu Z., Zheng H., Li Y., Steiner C.C.,
RA   Lam T.T., Lin S., Zhang Q., Li G., Tian J., Gong T., Liu H., Zhang D.,
RA   Fang L., Ye C., Zhang J., Hu W., Xu A., Ren Y., Zhang G., Bruford M.W.,
RA   Li Q., Ma L., Guo Y., An N., Hu Y., Zheng Y., Shi Y., Li Z., Liu Q.,
RA   Chen Y., Zhao J., Qu N., Zhao S., Tian F., Wang X., Wang H., Xu L., Liu X.,
RA   Vinar T., Wang Y., Lam T.W., Yiu S.M., Liu S., Zhang H., Li D., Huang Y.,
RA   Wang X., Yang G., Jiang Z., Wang J., Qin N., Li L., Li J., Bolund L.,
RA   Kristiansen K., Wong G.K., Olson M., Zhang X., Li S., Yang H., Wang J.,
RA   Wang J.;
RT   "The sequence and de novo assembly of the giant panda genome.";
RL   Nature 463:311-317(2010).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that specifically binds poly-ADP-
CC       ribosylated (PARsylated) proteins and mediates their ubiquitination and
CC       subsequent degradation. May regulate many important biological
CC       processes, such as cell survival and DNA damage response. Acts as an
CC       activator of the Wnt signaling pathway by mediating the ubiquitination
CC       of PARsylated AXIN1 and AXIN2, 2 key components of the beta-catenin
CC       destruction complex. Acts in cooperation with tankyrase proteins (TNKS
CC       and TNKS2), which mediate PARsylation of target proteins AXIN1, AXIN2,
CC       BLZF1, CASC3, TNKS and TNKS2. Recognizes and binds tankyrase-dependent
CC       PARsylated proteins via its WWE domain and mediates their
CC       ubiquitination. May regulate TNKS and TNKS2 subcellular location,
CC       preventing aggregation at a centrosomal location. Neuroprotective
CC       protein. Protects the brain against N-methyl-D-aspartate (NMDA)
CC       receptor-mediated glutamate excitotoxicity and ischemia, by interfering
CC       with PAR-induced cell death, called parthanatos. Prevents nuclear
CC       translocation of AIFM1 in a PAR-binding dependent manner. Does not
CC       affect PARP1 activation. Protects against cell death induced by DNA
CC       damaging agents, such as N-methyl-N-nitro-N-nitrosoguanidine (MNNG) and
CC       rescues cells from G1 arrest. Promotes cell survival after gamma-
CC       irradiation. Facilitates DNA repair. Neuroprotective protein. Protects
CC       the brain against N-methyl-D-aspartate (NMDA) receptor-mediated
CC       glutamate excitotoxicity and ischemia, by interfering with PAR-induced
CC       cell death, called parthanatos. Prevents nuclear translocation of AIFM1
CC       in a PAR-binding dependent manner. Does not affect PARP1 activation (By
CC       similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27;
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Can form homooligomers. Interacts with PARsylated AXIN1,
CC       AXIN2, BLZF1, CASC3, H1-2, IPO7, LIG3, NCL, PARP1, XRCC1, XRCC5 and
CC       XRCC6. Interacts with DDB1, DHX15, IQGAP1, LRPPRC, PARP2, PRKDC,
CC       RUVBL2, TNKS1 and TNKS2. Binding often leads to interactor
CC       ubiquitination, in the presence of the appropriate E1 and E2 enzymes,
CC       and proteasomal degradation. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250}. Nucleus
CC       {ECO:0000250}. Note=Translocates to the nucleus after DNA damage, such
CC       as laser-induced DNA breaks, and concentrates at DNA breaks. This
CC       translocation requires PARP1 activation and PAR-binding. {ECO:0000250}.
CC   -!- DOMAIN: The WWE domain mediates non-covalent poly(ADP-ribose)-binding.
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitinated; autoubiquitinated. Autoubiquitination is enhanced
CC       upon poly(ADP-ribose)-binding. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GL192419; EFB13674.1; -; Genomic_DNA.
DR   AlphaFoldDB; D2H0Y8; -.
DR   BMRB; D2H0Y8; -.
DR   SMR; D2H0Y8; -.
DR   STRING; 9646.ENSAMEP00000021212; -.
DR   eggNOG; KOG0824; Eukaryota.
DR   HOGENOM; CLU_067425_0_0_1; -.
DR   InParanoid; D2H0Y8; -.
DR   OMA; KTNESCA; -.
DR   UniPathway; UPA00143; -.
DR   Proteomes; UP000008912; Unassembled WGS sequence.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0072572; F:poly-ADP-D-ribose binding; ISS:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IEA:InterPro.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISS:UniProtKB.
DR   GO; GO:0051865; P:protein autoubiquitination; ISS:UniProtKB.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; ISS:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   CDD; cd16546; RING-HC_RNF146; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   Gene3D; 3.30.720.50; -; 1.
DR   InterPro; IPR044110; RING-HC_RNF146.
DR   InterPro; IPR033509; RNF146.
DR   InterPro; IPR004170; WWE-dom.
DR   InterPro; IPR018123; WWE-dom_subgr.
DR   InterPro; IPR037197; WWE_dom_sf.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR13417:SF2; PTHR13417:SF2; 1.
DR   Pfam; PF02825; WWE; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00678; WWE; 1.
DR   SUPFAM; SSF117839; SSF117839; 1.
DR   PROSITE; PS50918; WWE; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   3: Inferred from homology;
KW   Cytoplasm; Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transferase; Ubl conjugation; Ubl conjugation pathway;
KW   Wnt signaling pathway; Zinc; Zinc-finger.
FT   CHAIN           1..359
FT                   /note="E3 ubiquitin-protein ligase RNF146"
FT                   /id="PRO_0000409501"
FT   DOMAIN          91..167
FT                   /note="WWE"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00248"
FT   ZN_FING         36..74
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          259..359
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        259..275
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        295..325
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         107
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250"
FT   BINDING         110
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250"
FT   BINDING         114
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250"
FT   BINDING         144
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250"
FT   BINDING         153
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250"
FT   BINDING         163
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250"
FT   BINDING         175
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         290
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5XIK5"
FT   MOD_RES         294
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5XIK5"
FT   CROSSLNK        84
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NTX7"
FT   CROSSLNK        94
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NTX7"
FT   CROSSLNK        130
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NTX7"
FT   CROSSLNK        175
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NTX7"
SQ   SEQUENCE   359 AA;  38839 MW;  DFE28DC43E92D4CD CRC64;
     MAGCGEIDHS VNMLPTNRKA NESCANPAPS LTVPECAICL QTCVHPVSLP CKHVFCYLCV
     KGASWLGKRC ALCRQEIPED FLDKPTLLSP EELKAASRGN GEYAWYYEGR NGWWQYDERT
     SRELEDAFSK GKKSTEMLIA GFLYVADLEN MVQYRRNEHG RRRKIKRDII DIPKKGVAGL
     RLDCEANTVN LARESSADGA DSVSAQSGAS SVQPLVSSLR PLTSVDGQLT SPATPSPDAS
     TSLEDSFAHL QLSGDSIAER SHRGEGEEDH ESPSSGRVPA PDTSVEETES DASSDSEDVS
     ALVAQHSLTQ QRLLVPNANQ TVSDRSDRSG IDRSVAGGGT VNAGVRSRRP DGQCTVTEV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024